Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roth Mkm started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report released on Wednesday morning, Briefing.com reports. The brokerage issued a buy rating and a $23.00 price target on the stock. TERN has been the topic of a number of other reports. UBS Group initiated coverage on shares of […]
Equities research analysts at Roth Mkm initiated coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report issued to clients and investors on Wednesday, Briefing.com reports. The firm set a “buy” rating and a $23.00 price target on the stock. Roth Mkm’s price objective points to a potential upside of 103.54% […]
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating)’s stock price traded up 6% during mid-day trading on Monday . The company traded as high as $11.05 and last traded at $10.70. 39,619 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 349,938 shares. The stock had previously closed at […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) and TransCode Therapeutics (NASDAQ:RNAZ – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 15.9% of TransCode Therapeutics shares […]
BMO Capital Markets assumed coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research note released on Monday, The Fly reports. The brokerage issued an outperform rating and a $18.00 price target on the stock. Several other equities analysts have also recently weighed in on TERN. UBS Group initiated coverage on shares […]